Spine index
1024 compound records
Every row is generated from the spine with its source, fetch time, licence class and verdict.
- Oxaliplatin · 1 trial · 1 approval
- Carfilzomib · 2 trials · 2 approvals
- Belzutifan · 3 trials · 1 approval
- Obrixtamig · 2 trials · 0 approvals
- Tirzepatide · 2 trials · 2 approvals
- Mk-1406 · 2 trials · 0 approvals
- Selinexor · 2 trials · 1 approval
- Nivolumab · 2 trials · 3 approvals
- Ziftomenib · 1 trial · 1 approval
- Mirdametinib · 1 trial · 1 approval
- Survodutide · 2 trials · 0 approvals
- Durvalumab · 5 trials · 0 approvals
- Selatogrel · 2 trials · 0 approvals
- Biospecimen Collection · 40 trials · 0 approvals
- Busulfan · 2 trials · 0 approvals
- Dasatinib · 1 trial · 1 approval
- Nt-0796 · 2 trials · 0 approvals
- Vepdegestrant · 1 trial · 1 approval
- Bi 764532 · 2 trials · 0 approvals
- Treprostinil Palmitil Inhalation Powder · 3 trials · 0 approvals
- Daraxonrasib · 2 trials · 1 approval
- Gadobutrol · 1 trial · 1 approval
- Cg-Bm1 · 2 trials · 0 approvals
- Pembrolizumab · 6 trials · 0 approvals
- Teriflunomide · 1 trial · 1 approval
- Gemcitabine · 2 trials · 0 approvals
- Telisotuzumab Adizutecan · 3 trials · 0 approvals
- Biopsy Procedure · 6 trials · 0 approvals
- Pacritinib · 2 trials · 0 approvals
- Remibrutinib · 1 trial · 1 approval
- Allogeneic Stem Cell Transplant · 2 trials · 0 approvals
- Sonrotoclax · 3 trials · 1 approval
- Ifinatamab Deruxtecan · 2 trials · 0 approvals
- Carboplatin · 5 trials · 1 approval
- T-Dxd · 2 trials · 0 approvals
- Mk-1045 · 2 trials · 0 approvals
- [18f]-Pi2620 · 2 trials · 0 approvals
- Psilocybin · 5 trials · 0 approvals
- Atezolizumab · 10 trials · 1 approval
- Fludarabine · 2 trials · 0 approvals
- Cyclophosphamide · 4 trials · 3 approvals
- Kxv01 Tcr Lentinvivo Injection · 2 trials · 0 approvals
- Azacitidine · 4 trials · 2 approvals
- Tocilizumab · 1 trial · 1 approval
- Olaparib · 1 trial · 1 approval
- Spy001 · 2 trials · 0 approvals
- Ketamine Hydrochloride · 1 trial · 1 approval
- Infliximab · 1 trial · 1 approval
- Toripalimab · 3 trials · 0 approvals
- Galvokimig · 2 trials · 0 approvals
- Rozanolixizumab · 5 trials · 0 approvals
- Adagrasib · 2 trials · 1 approval
- Laboratory Biomarker Analysis · 2 trials · 0 approvals
- Abbv-706 · 2 trials · 0 approvals
- Zanubrutinib · 1 trial · 2 approvals
- Aadvac1 · 2 trials · 0 approvals
- Dupilumab · 1 trial · 1 approval
- Autologous Hematopoietic Stem Cell Transplantation · 3 trials · 0 approvals
- Placebo · 5 trials · 0 approvals
- Semaglutide · 1 trial · 3 approvals
- Enzalutamide · 2 trials · 1 approval
- Ibuprofen · 1 trial · 5 approvals
- Risankizumab · 2 trials · 0 approvals
- Belinostat · 1 trial · 1 approval
- Adavosertib · 2 trials · 0 approvals
- Bevacizumab · 3 trials · 0 approvals
- Nemtabrutinib · 2 trials · 0 approvals
- Doravirine · 1 trial · 2 approvals
- Thiotepa · 1 trial · 1 approval
- Ruxolitinib · 2 trials · 1 approval
- Metreleptin · 2 trials · 1 approval
- Docetaxel · 1 trial · 2 approvals
- Curalin · 2 trials · 0 approvals
- Cobimetinib · 2 trials · 0 approvals
- Brentuximab Vedotin · 1 trial · 1 approval
- Avelumab · 2 trials · 1 approval
- Rap-219 · 2 trials · 0 approvals
- Computed Tomography · 2 trials · 0 approvals
- Gabapentin · 1 trial · 1 approval
- Alpelisib · 1 trial · 1 approval
- Elranatamab · 1 trial · 1 approval
- Nerandomilast · 1 trial · 2 approvals
- Orelabrutinib · 3 trials · 0 approvals
- Aflibercept · 1 trial · 1 approval
- Finerenone · 1 trial · 1 approval
- Amoxicillin · 1 trial · 1 approval
- Pegcetacoplan · 1 trial · 2 approvals
- Upadacitinib · 2 trials · 1 approval
- Tenecteplase · 1 trial · 1 approval
- Fezolinetant · 1 trial · 1 approval
- Karxt · 3 trials · 0 approvals
- Apalutamide · 1 trial · 1 approval
- Cyb003 · 2 trials · 0 approvals
- Deucravacitinib · 2 trials · 1 approval
- Vasopressin · 1 trial · 1 approval
- Afimkibart · 2 trials · 0 approvals
- Calderasib · 4 trials · 0 approvals
- Tranexamic Acid · 2 trials · 1 approval
- Bimekizumab · 2 trials · 0 approvals
- Crovalimab · 2 trials · 0 approvals
- Anastrozole · 2 trials · 1 approval
- Ibrutinib · 1 trial · 1 approval
- Venetoclax · 1 trial · 1 approval
- Pg4 · 2 trials · 0 approvals
- Inavolisib · 1 trial · 1 approval
- Atropine · 1 trial · 1 approval
- Radiotherapy Followed By Chemotherapy · 2 trials · 0 approvals
- Odevixibat · 1 trial · 1 approval
- Ublituximab · 2 trials · 0 approvals
- Ravulizumab-Cwvz · 0 trials · 1 approval
- Linezolid · 0 trials · 2 approvals
- Eculizumab · 0 trials · 1 approval
- Levothyroxine Sodium · 0 trials · 2 approvals
- Luspatercept-Aamt · 0 trials · 1 approval
- Dextrose · 0 trials · 7 approvals
- Bepirovirsen · 0 trials · 1 approval
- Dostarlimab-Gxly · 0 trials · 1 approval
- Epinephrine · 0 trials · 9 approvals
- Sodium Ctirate · 0 trials · 1 approval
- Calcuim Chloride · 0 trials · 1 approval
- Imatinib Mesylate · 0 trials · 2 approvals
- Berotralstat Dihydrochloride · 0 trials · 2 approvals
- Avapritinib · 0 trials · 1 approval
- Phentolamine Mesylate · 0 trials · 1 approval
- Trofinetide · 0 trials · 2 approvals
- Brytly (Apraclonidine) · 0 trials · 1 approval
- Rivaroxaban · 0 trials · 2 approvals
- Methotrexate Sodium · 0 trials · 2 approvals
- Methotrexate · 0 trials · 2 approvals
- Satralizumab · 0 trials · 1 approval
- Secukinumab · 0 trials · 1 approval
- Cefixime · 0 trials · 2 approvals
- Cevimeline Hydrochloride · 0 trials · 1 approval
- Sulfasalazine · 0 trials · 1 approval
- Mesalamine · 0 trials · 1 approval
- Balsalazide Disodium · 0 trials · 1 approval
- Nogapendekin Alfa Inbakicept-Pmln · 0 trials · 1 approval
- Etanercept · 0 trials · 1 approval
- Olsalazine Sodium · 0 trials · 1 approval
- Clesrovimab-Cfor · 0 trials · 1 approval
- Copper · 0 trials · 2 approvals
- Ferric Oxyhydroxide · 0 trials · 1 approval
- Iopamidol · 0 trials · 2 approvals
- Pritelivir · 0 trials · 1 approval
- Budesonide, Glycopyrrolate, And Formoterol Fumarate · 0 trials · 1 approval
- Atezolizumab And Hyaluronidase-Tqjs · 0 trials · 1 approval
- Isotretinoin · 0 trials · 1 approval
- Tucatinib · 0 trials · 1 approval
- Benzoyl Peroxide · 0 trials · 1 approval
- Diazoxide · 0 trials · 1 approval
- Sodium Bicarbonate · 0 trials · 2 approvals
- Corticotropin-Zinc Hydroxide · 0 trials · 1 approval
- Corticotropin · 0 trials · 1 approval
- Pirtobrutinib · 0 trials · 1 approval
- Acetaminophen · 0 trials · 3 approvals
- Trabectedin · 0 trials · 3 approvals
- Entrectinib · 0 trials · 1 approval
- Procarbazine Hydrochloride · 0 trials · 1 approval
- Orlistat · 0 trials · 2 approvals
- Lurbinectedin · 0 trials · 1 approval
- Mavacamten · 0 trials · 1 approval
- Rituximab-Arrx · 0 trials · 1 approval
- Aflibercept-Boav · 0 trials · 1 approval
- Denosumab-Adet · 0 trials · 1 approval
- Tocilizumab-Anoh · 0 trials · 1 approval
- Rituximab-Pvvr · 0 trials · 1 approval
- Mitapivat Sulfate · 0 trials · 1 approval
- Tiratricol · 0 trials · 1 approval
- Cetirizine Hydrochloride · 0 trials · 5 approvals
- Argatroban · 0 trials · 7 approvals
- Tavapadon · 0 trials · 1 approval
- Apixaban · 0 trials · 3 approvals
- Loratadine · 0 trials · 3 approvals
- Adalimumab-Aqvh · 0 trials · 1 approval
- Diclofenac Sodium · 0 trials · 2 approvals
- Lamotrigine Hemifumarate · 0 trials · 1 approval
- Zilurgisertib Fumarate · 0 trials · 1 approval
- Daptomycin · 0 trials · 4 approvals
- Lenvatinib Mesylate · 0 trials · 1 approval
- Diazepam · 0 trials · 3 approvals
- Teprotumumab-Trbw · 0 trials · 1 approval
- Cefotaxime Sodium · 0 trials · 1 approval
- Rosuvastatin Calcium · 0 trials · 1 approval
- Lirafugratinib Hydrochloride · 0 trials · 1 approval
- Paroxetine Hydrochloride · 0 trials · 1 approval
- Insulin Efsitora Alfa-Gobe · 0 trials · 1 approval
- Treprostinil · 0 trials · 2 approvals
- Darolutamide · 0 trials · 1 approval
- Valsartan · 0 trials · 2 approvals
- Asciminib Hydrochloride · 0 trials · 1 approval
- Carbon Dioxide, Usp · 0 trials · 2 approvals
- Sotatercept-Csrk · 0 trials · 1 approval
- Abemaciclib · 0 trials · 1 approval
- Levacetylleucine · 0 trials · 1 approval
- Imlunestrant Tosylate · 0 trials · 1 approval
- Esketamine Hydrochloride · 0 trials · 1 approval
- Empagliflozin · 0 trials · 3 approvals
- Capivasertib · 0 trials · 1 approval
- Glucagon Hydrochloride · 0 trials · 1 approval
- Taletrectinib Adipate · 0 trials · 1 approval
Showing the first 200 of 1024. The full set is in sitemap.xml.